Skip to main content
TipRanks
Go Ultimate75% OFF

Steven Koon.Ching Lee Insider Profile

4 Followers

Steven Koon.Ching Lee, former Chief Executive at Summit Therapeutics, holds 2.58M shares in Summit Therapeutics (Ticker: GB:SUMM). Most recently, Steven Koon.Ching Lee Bought 150,000 shares of Summit Therapeutics on Aug 04, 2010 for an estimated value of 4.50K .

Steven Koon.Ching Lee's Trading History

SUMM
Summit Therapeutics
Aug 04, 2010―Informative Buy4.50K£968.43K
GB:SUMM
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 04, 2010Informative Buy£4.50K150,000£3.00――
Dec 11, 2009Informative Buy£10.25K2,050,000£0.00――
Nov 02, 2009Informative Buy£11.50K200,000£6.00――

You May Also Like

Steven Koon.Ching Lee insider profile FAQ

What is the percentage of profitable transactions made by Steven Koon.Ching Lee?
The percentage of profitable transactions made by Steven Koon.Ching Lee is 33%.
What is the average return per transaction made by Steven Koon.Ching Lee?
The average return per transaction made by Steven Koon.Ching Lee is 4.80%.
What stocks does Steven Koon.Ching Lee hold?
Steven Koon.Ching Lee holds: GB:SUMM stocks.
What was Steven Koon.Ching Lee’s latest transaction?
Steven Koon.Ching Lee’s latest transaction was an Informative Buy of 4.50K .
What is Steven Koon.Ching Lee's role in Summit Therapeutics?
Steven Koon.Ching Lee's role in Summit Therapeutics is Chief Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.